214 related articles for article (PubMed ID: 17003232)
41. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
Haruna Y; Morita Y; Yada T; Satoh M; Fox DA; Kashihara N
Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
[TBL] [Abstract][Full Text] [Related]
42. Contractions to histamine in pulmonary and mesenteric arteries from endotoxemic rabbits: modulation by vascular expressions of inducible nitric-oxide synthase and histamine H1-receptors.
Matsuda N; Hattori Y; Zhang XH; Fukui H; Kemmotsu O; Gando S
J Pharmacol Exp Ther; 2003 Oct; 307(1):175-81. PubMed ID: 12954799
[TBL] [Abstract][Full Text] [Related]
43. Chronic fluvastatin treatment alters vascular contraction by inhibiting the Rho/Rho-kinase pathway.
Kansui Y; Fujii K; Goto K; Oniki H; Iida M
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):673-8. PubMed ID: 16895538
[TBL] [Abstract][Full Text] [Related]
44. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
45. Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway.
Inoue T; Suzuki Y; Yoshimaru T; Ra C
J Leukoc Biol; 2008 May; 83(5):1218-29. PubMed ID: 18285401
[TBL] [Abstract][Full Text] [Related]
46. Phosphorylated endothelial NOS Ser1177 via the PI3K/Akt pathway is depressed in the brain of stroke-prone spontaneously hypertensive rat.
Yoshitomi H; Xu Q; Gao M; Yamori Y
J Stroke Cerebrovasc Dis; 2011; 20(5):406-12. PubMed ID: 20813549
[TBL] [Abstract][Full Text] [Related]
47. Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/akt pathway.
Yu J; Akishita M; Eto M; Ogawa S; Son BK; Kato S; Ouchi Y; Okabe T
Endocrinology; 2010 Apr; 151(4):1822-8. PubMed ID: 20194727
[TBL] [Abstract][Full Text] [Related]
48. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells.
Xenos ES; Stevens SL; Freeman MB; Cassada DC; Goldman MH
Ann Vasc Surg; 2005 May; 19(3):386-92. PubMed ID: 15818460
[TBL] [Abstract][Full Text] [Related]
49. A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA.
Kano H; Hayashi T; Sumi D; Esaki T; Asai Y; Thakur NK; Jayachandran M; Iguchi A
Biochem Biophys Res Commun; 1999 Jun; 259(2):414-9. PubMed ID: 10362523
[TBL] [Abstract][Full Text] [Related]
50. Statin treatment after onset of sepsis in a murine model improves survival.
Merx MW; Liehn EA; Graf J; van de Sandt A; Schaltenbrand M; Schrader J; Hanrath P; Weber C
Circulation; 2005 Jul; 112(1):117-24. PubMed ID: 15998696
[TBL] [Abstract][Full Text] [Related]
51. Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells.
Eto M; Rathgeb L; Cosentino F; Kozai T; Lüscher TF
J Cardiovasc Pharmacol; 2006 May; 47(5):663-7. PubMed ID: 16775505
[TBL] [Abstract][Full Text] [Related]
52. Activation of IKKbeta by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cells.
Kim F; Tysseling KA; Rice J; Gallis B; Haji L; Giachelli CM; Raines EW; Corson MA; Schwartz MW
J Mol Cell Cardiol; 2005 Aug; 39(2):327-34. PubMed ID: 15978611
[TBL] [Abstract][Full Text] [Related]
53. Exercise improves the dilatation function of mesenteric arteries in postmyocardial infarction rats via a PI3K/Akt/eNOS pathway-mediated mechanism.
Wang Y; Wang S; Wier WG; Zhang Q; Jiang H; Li Q; Chen S; Tian Z; Li Y; Yu X; Zhao M; Liu J; Yang J; Zhang J; Zang W
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2097-106. PubMed ID: 20935150
[TBL] [Abstract][Full Text] [Related]
54. Redox regulation of the signaling pathways leading to eNOS phosphorylation.
Tanaka T; Nakamura H; Yodoi J; Bloom ET
Free Radic Biol Med; 2005 May; 38(9):1231-42. PubMed ID: 15808421
[TBL] [Abstract][Full Text] [Related]
55. Vasostatin 1 activates eNOS in endothelial cells through a proteoglycan-dependent mechanism.
Ramella R; Boero O; Alloatti G; Angelone T; Levi R; Gallo MP
J Cell Biochem; 2010 May; 110(1):70-9. PubMed ID: 20213742
[TBL] [Abstract][Full Text] [Related]
56. The preventive effect of uncarboxylated osteocalcin against free fatty acid-induced endothelial apoptosis through the activation of phosphatidylinositol 3-kinase/Akt signaling pathway.
Jung CH; Lee WJ; Hwang JY; Lee MJ; Seol SM; Kim YM; Lee YL; Park JY
Metabolism; 2013 Sep; 62(9):1250-7. PubMed ID: 23639572
[TBL] [Abstract][Full Text] [Related]
57. Direct interaction of the cell division cycle 37 homolog inhibits endothelial nitric oxide synthase activity.
Harris MB; Bartoli M; Sood SG; Matts RL; Venema RC
Circ Res; 2006 Feb; 98(3):335-41. PubMed ID: 16410463
[TBL] [Abstract][Full Text] [Related]
58. Somatostatin modulates PI3K-Akt, eNOS and NHE activity in the ciliary epithelium.
Ghosh S; Choritz L; Geibel J; Coca-Prados M
Mol Cell Endocrinol; 2006 Jul; 253(1-2):63-75. PubMed ID: 16764985
[TBL] [Abstract][Full Text] [Related]
59. Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies.
Sugano R; Matsuoka H; Haramaki N; Umei H; Murase E; Fukami K; Iida S; Ikeda H; Imaizumi T
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1262-7. PubMed ID: 15790932
[TBL] [Abstract][Full Text] [Related]
60. Erythropoietin improves skeletal muscle microcirculation through the activation of eNOS in a mouse sepsis model.
Kao RL; Martin CM; Xenocostas A; Huang W; Rui T
J Trauma; 2011 Nov; 71(5 Suppl 1):S462-7. PubMed ID: 22072004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]